ghk-cu clinical trial human skin wound healing randomized for & Healing: Current Evidence GHK-Cu for Skin Rejuvenation -

Englewood Cliffs, New Jersey, USA: Prentice Hall

Czechia 99.6 % purity confirmed by COA Assay content verified at 3.64 mg Identification confirmed by FTIR spectrum and retention time analysis Molecular ion mass identified at 1800 Da Endotoxin level below 0.001 EU/mg No detectable heavy metals or microbial contamination Research-grade peptide compound For research use only not for human or veterinary use For laboratory research only

Classical EDS (cEDS) also involves hypermobile joints along with highly elastic skin and abnormal scarring

Researchers should always review available manufacturer documentation, published stability data, and internal laboratory procedures when preparing peptides for experimental use